LifeLabs To Drop $1.2B On Lab Testing Rival

Law360, New York (June 25, 2013, 1:57 PM EDT) -- Canadian laboratory testing company LifeLabs Medical Laboratory Services has agreed to buy rival CML HealthCare Inc. in a CA$1.22 billion (US$1.16 billion) deal aimed especially at expanding its footprint in Ontario, the companies announced Tuesday.

Under the terms of the deal, CML shareholders will receive CA$10.75 per share — a nearly 50 percent premium over the closing price Monday — for a total cash outlay by LifeLabs of about CA$965 million, with the company also agreeing to take on CML’s CA$255 million in outstanding debt, the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.